Abstract:To investigate whether tumor cell lysate-pulsed (TP) dendritic cells (DCs) induce cytotoxic T lymphocyte (CTL) activity against colon cancer in vitro and in vivo . Hematopoietic progenitor cells were magnetically isolated from BALB/c mice bone marrow cells. These cells were cultured with cytokines GM-CSF, IL-4, and TNFα to induce their maturation. They were analyzed by morphological observation and phenotype analysis. DCs were pulsed with tumor cell lysate obtained by rapid freezing and thawing at a 1:3 DC:tumor cell ratio. CTL activity and interferon gamma (IFNγ) secretion was evaluated ex vivo. In order to determine whether or not vaccination with CT26 TP DCs induce the therapeutic potential in the established colon tumor model, CT26 colon tumor cells were implanted subcutaneously (s.c.) in the midflank of naïve BALB/c mice. Tumor-bearing mice were injected with vaccination with CT26 TP DCs on days 3 and 10. Tumor growth was assessed every 2–3 days. Finally, CTL activity and IFNγ secretion were evaluated in immunized mice. Hematopoietic progenitor cells from mice bone marrow cells cultured with cytokines for 8 days showed the character of typical mature DCs. Morphologically, these cells were large with oval or irregularly shaped nuclei and with many small dendrites. Phenotypically, FACS analysis showed that they expressed high levels of MHC II, CD11b, CD80, and CD86 antigen, and were negative for CD8α. However, immature DCs cultured with cytokines for 5 days did not have typical DCs phenotypic markers. Ex vivo primed T cells with CT26 TP DCs were able to induce effective CTL activity against CT26 tumor cells, but not B16 tumor cells ( E : T = 100:1, 60.36 ± 7.11% specific lysis in CT26 group vs. 17.36 ± 4.10% specific lysis in B16 group), and produced higher levels of IFNγ when stimulated with CT26 tumor cells but not when stimulated with B16 tumor cells (1210.33 ± 72.15 pg/ml in CT26 group vs. 182.25 ± 25.51 pg/ml in B16 group, P < 0.01). Vaccination with CT26 TP DCs could induce anti-tumor immunity against CT26 colon tumor in murine therapeutic models (tumor volume on day 19: CT26 TP DCs 342 ± 55 mm 3 vs. the other control groups, P < 0.05). In addition, all splenic CD3 + T cells obtained from mice vaccinated with CT26 TP DCs produced high levels of IFNγ and shown specific cytotoxic activity against CT26 tumor cells, but no cytotoxic activity when stimulated with B16 tumor cells. Tumor cell lysate-pulsed DCs can induce tumor-specific CTL activity against colon cancer in vitro and in vivo .

Anti-tumor Response of Dendritic Cells after Pulsed with Whole Tumor Cell Lysates of Prostate Cancer Cell Line

The Immunotherapeutic Effect of Dendritic Cells Vaccine Modified with IFN-γ Inducible Protein-10 Gene and Tumor Cell Lysate on Mice with Prostate Cancer

Telomerase Pulsed Dendritic Cells Induced Antitumor Immune Response Against Prostate Cancer in Vitro

Experimental Study of Treatment of Prostate Cancer with Murine Dendritic Cells Pulsed with Tumor Cell RNA

Antitumor Immunity by a Dendritic Cell Vaccine Encoding Secondary Lymphoid Chemokine and Tumor Lysate on Murine Prostate Cancer

Dendritic Cells Loaded with Prostate Stem Cell Antigen: Preparation of a Prostate Cancer Vaccines Against Prostatic Carcinoma

The Experimental Study about the Immunizing Treatment of Prostate Cancer Induced by Sensitized DC

Immunotherapeutic effect of dendritic cell vaccine modified with the CXCL10 gene and tumor cell RNA on mice with prostate cancer

Tumor cell lysate-pulsed dendritic cells induce a T cell response against colon cancer in vitro and in vivo

Research of dendritic cells pulsed with PSA peptide inducing specific CTL in vitro

TGF-β insensitive dendritic cells: an efficient vaccine for murine prostate cancer

Induction of Prostate Cancer-Specific CTLs with Dendritic Cells Pulsed by Different Types of Tumor Antigens

Immunotherapy of mouse renal cell carcinoma with tumor lysate-pulsed dendritic cells

Immune Response Against Prostate Cancer Cells Induced by Recombinant Adenovirus Encoding Truncated Prostate Specific Membrane Antigen Gene and 4-1BBL Gene Modified Dendritic Cells in Vitro

Effect of dendritic cells sensitized by tumor cells lysates on the murine breast cancer

Antitumor Effects of Ad-PSMA-Pulsed Dendritic Cells Cocultured with Autologous Cytokine-Induced Killer Cells on Prostate Cancer in Vivo

Dendritic cell trafficking in tumor-bearing mice

Anti-tumor Immune Response Induced by Dendritic Cells Transduced with Truncated PSMA IRES 4-1BBL Recombinant Adenoviruses.

Eliciting Cytotoxic T Lymphocytes Against Human Laryngeal Cancer-Derived Antigens: Evaluation of Dendritic Cells Pulsed with a Heat-Treated Tumor Lysate and Other Antigen-Loading Strategies for Dendritic-Cell-based Vaccination

Induction of T cell responses against autologous ovarian tumors with whole tumor cell lysate-pulsed dendritic cells.

Dendritic Cells Loaded with CD44+ CT-26 Colon Cell Lysate Evoke Potent Antitumor Immune Responses.